PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
Go back to PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance| (NASDAQ: PRCT) | Delayed: 21.06 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $21.06 | 52 Week High | $ | |||
| Open | $21.06 | 52 Week Low | $ | |||
| Day High | $21.06 | P/E | N/A | |||
| Day Low | $21.06 | EPS | $ | |||
| Volume | 1,205 | |||||

